Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 2.24M
2: EX-10.10 Material Contract HTML 104K
3: EX-10.16 Material Contract HTML 84K
4: EX-10.17 Material Contract HTML 40K
5: EX-21.1 Subsidiaries List HTML 30K
6: EX-23.1 Consent of Expert or Counsel HTML 28K
11: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 64K
Awarded Compensation
7: EX-31.1 Certification -- §302 - SOA'02 HTML 33K
8: EX-31.2 Certification -- §302 - SOA'02 HTML 33K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 30K
10: EX-32.2 Certification -- §906 - SOA'02 HTML 30K
17: R1 Cover HTML 95K
18: R2 Audit Information HTML 34K
19: R3 Consolidated Balance Sheets HTML 145K
20: R4 Consolidated Balance Sheets (Parenthetical) HTML 49K
21: R5 Consolidated Statements of Operations and HTML 126K
Comprehensive Income (Loss)
22: R6 Consolidated Statements of Stockholders' Equity HTML 94K
23: R7 Consolidated Statements of Cash Flows HTML 150K
24: R8 Organization and Basis of Presentation HTML 33K
25: R9 Summary of Significant Accounting Policies HTML 110K
26: R10 Financial Instruments and Fair Value Measurements HTML 81K
27: R11 Cash Equivalents and Short-Term Investments HTML 81K
28: R12 Business Combinations HTML 67K
29: R13 Balance Sheet Components HTML 62K
30: R14 Goodwill and intangible assets HTML 57K
31: R15 Commitments and Contingencies HTML 58K
32: R16 Debt HTML 38K
33: R17 Convertible Debt HTML 39K
34: R18 Stock-Based Compensation HTML 86K
35: R19 Income Taxes HTML 120K
36: R20 Revenue HTML 55K
37: R21 Equity Method Investments HTML 35K
38: R22 Net Income (Loss) Per Share HTML 61K
39: R23 Pay vs Performance Disclosure HTML 40K
40: R24 Insider Trading Arrangements HTML 34K
41: R25 Summary of Significant Accounting Policies HTML 184K
(Policies)
42: R26 Summary of Significant Accounting Policies HTML 55K
(Tables)
43: R27 Financial Instruments and Fair Value Measurements HTML 77K
(Tables)
44: R28 Cash Equivalents and Short-Term Investments HTML 84K
(Tables)
45: R29 Business Combinations (Tables) HTML 67K
46: R30 Balance Sheet Components (Tables) HTML 65K
47: R31 Goodwill and intangible assets (Tables) HTML 62K
48: R32 Commitments and Contingencies (Tables) HTML 57K
49: R33 Stock-Based Compensation (Tables) HTML 82K
50: R34 Income Taxes (Tables) HTML 119K
51: R35 Revenue (Tables) HTML 50K
52: R36 Net Income (Loss) Per Share (Tables) HTML 61K
53: R37 Organization and Basis of Presentation (Details) HTML 31K
54: R38 Summary of Significant Accounting Policies - HTML 37K
Schedule of Reconciliation of Cash, Cash
Equivalents and Restricted Cash (Details)
55: R39 Summary of Significant Accounting Policies - HTML 49K
Additional Information (Details)
56: R40 Summary of Significant Accounting Policies - HTML 37K
Summary of Activity in Allowance for Doubtful
Accounts (Details)
57: R41 Summary of Significant Accounting Policies HTML 40K
(Details)
58: R42 Financial Instruments and Fair Value Measurements HTML 104K
- Schedule of Financial Assets and Liabilities
Measured at Fair Value (Details)
59: R43 Financial Instruments and Fair Value Measurements HTML 44K
- Additional Information (Details)
60: R44 Cash Equivalents and Short-Term Investments - HTML 70K
Summary of Cash Equivalents and Short-Term
Investments (Details)
61: R45 Cash Equivalents and Short-Term Investments - HTML 37K
Additional Information (Details)
62: R46 Cash Equivalents and Short-Term Investments - HTML 40K
Summary of Remaining Contractual Maturities for
Available-for-sale Securities (Details)
63: R47 Business Combination - Narrative (Details) HTML 60K
64: R48 Business Combination - Calculation of HTML 37K
Consideration Transferred (Details)
65: R49 Business Combination - Assets Acquired, HTML 77K
Liabilities Assumed (Details)
66: R50 Business Combination - Intangible Assets (Details) HTML 41K
67: R51 Business Combination - Pro Forma Information HTML 34K
(Details)
68: R52 Balance Sheet Components - Schedule of Inventory HTML 38K
(Details)
69: R53 Balance Sheet Components - Schedule of Property HTML 52K
and Equipment (Details)
70: R54 Balance Sheet Components - Additional Information HTML 31K
(Details)
71: R55 Balance Sheet Components - Schedule of Accrued HTML 45K
Liabilities (Details)
72: R56 Goodwill and intangible assets - Changes in HTML 37K
Carrying Amount of Goodwill (Details)
73: R57 Goodwill and intangible assets - Schedule of HTML 61K
Finite and Indefinite-Lived Intangible Assets
(Details)
74: R58 Goodwill and intangible assets - Narrative HTML 30K
(Details)
75: R59 Goodwill and intangible assets - Future HTML 44K
Amortization Expense (Details)
76: R60 Commitments and Contingencies - Additional HTML 45K
Information (Details)
77: R61 Commitments and Contingencies - Components of HTML 35K
Lease Costs (Details)
78: R62 Commitments and Contingencies - Schedule of HTML 52K
Minimum Future Rental Payments (Details)
79: R63 Commitments and Contingencies - Schedule of Future HTML 41K
Leases, Lease Payments (Details)
80: R64 Debt (Details) HTML 92K
81: R65 Convertible Debt (Details) HTML 97K
82: R66 Stock-Based Compensation - Schedule of Total HTML 41K
Stock-Based Compensation (Details)
83: R67 Stock-Based Compensation - Additional Information HTML 91K
(Details)
84: R68 Stock-Based Compensation - Schedule of Option HTML 75K
Activity under 2009 Plan and 2019 Plan (Details)
85: R69 Stock-Based Compensation - Schedule of RSU HTML 59K
Activity under 2019 Plan (Details)
86: R70 Stock-Based Compensation - Schedule of Fair Value HTML 57K
of ESPP Shares Estimated Using Black-Scholes
Option Pricing Model Assumptions (Details)
87: R71 Income Taxes -Schedule of Income (Loss) Before HTML 38K
Income Taxes (Details)
88: R72 Income Taxes - Schedule of Current Income Tax HTML 57K
Provision (Details)
89: R73 Income Taxes - Components of Deferred Tax Assets HTML 66K
and Liabilities (Details)
90: R74 Income Taxes - Reconciliation of Statutory Federal HTML 59K
Income Tax (Details)
91: R75 Income Taxes - Additional Information (Details) HTML 65K
92: R76 Income Taxes - Schedule of Unrecognized Tax HTML 38K
Benefits (Details)
93: R77 Revenue - Schedule of Product Revenue Based on HTML 44K
Product Line and Location (Details)
94: R78 Revenue - Schedule of Product Revenue Based on HTML 42K
Location (Details)
95: R79 Equity Method Investments (Details) HTML 56K
96: R80 Net Income (Loss) Per Share - Components of Basic HTML 71K
and Diluted Net Income (Loss) Per Share (Details)
97: R81 Net Income (Loss) Per Share - Summary of HTML 42K
Outstanding Potentially Dilutive Common Stock
Equivalents Excluded from Calculation of Diluted
Net Income (Loss) Per Share (Details)
99: XML IDEA XML File -- Filing Summary XML 180K
102: XML XBRL Instance -- swav-20231231_htm XML 2.15M
98: EXCEL IDEA Workbook of Financial Report Info XLSX 188K
13: EX-101.CAL XBRL Calculations -- swav-20231231_cal XML 316K
14: EX-101.DEF XBRL Definitions -- swav-20231231_def XML 662K
15: EX-101.LAB XBRL Labels -- swav-20231231_lab XML 2.27M
16: EX-101.PRE XBRL Presentations -- swav-20231231_pre XML 1.33M
12: EX-101.SCH XBRL Schema -- swav-20231231 XSD 189K
100: JSON XBRL Instance as JSON Data -- MetaLinks 628± 968K
101: ZIP XBRL Zipped Folder -- 0001642545-24-000063-xbrl Zip 986K
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
1.I have reviewed this Annual Report on Form 10-K of Shockwave Medical, Inc.;
2. Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the
registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
